{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-198322","form_type":"8-K","ticker":"RAPP","cik":"0002012593","company_name":"Rapport Therapeutics, Inc.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.813505+00:00","generated_at":"2026-05-17T07:44:32.306419+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Rapport Therapeutics terminates ATM equity offering program; no shares sold","bullets":["Effective Sept 8, 2025, terminated the ATM prospectus under the S-3 registration statement.","Sales Agreement with Leerink and Cantor remains in effect but no sales without new filing.","No shares of common stock were issued or sold under the program as of termination date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-198322","json":"https://secwatch.observer/filing/0001193125-25-198322.json","markdown":"https://secwatch.observer/filing/0001193125-25-198322.md","text":"https://secwatch.observer/filing/0001193125-25-198322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2012593/000119312525198322/0001193125-25-198322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2012593/000119312525198322/d56083d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:44:32.306419+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}